Cargando…
Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
The rate of diagnosis of colonization/infection of the airways with Achromobacter xylosoxidans has increased in cystic fibrosis patients, but its clinical significance is still controversial. This retrospective, case-control study aimed to evaluate the clinical impact of A. xylosoxidans colonization...
Autores principales: | Firmida, M.C., Pereira, R.H.V., Silva, E.A.S.R., Marques, E.A., Lopes, A.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792508/ https://www.ncbi.nlm.nih.gov/pubmed/26909788 http://dx.doi.org/10.1590/1414-431X20155097 |
Ejemplares similares
-
Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
por: Firmida, Mônica Cássia, et al.
Publicado: (2017) -
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
por: Lambiase, A., et al.
Publicado: (2011) -
VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
por: Neuwirth, Catherine, et al.
Publicado: (2006) -
Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
por: Veschetti, Laura, et al.
Publicado: (2020) -
Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
por: Tetart, Macha, et al.
Publicado: (2019)